Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression

ABSTRACT:

SUBMITTER: Nazzaro M 

PROVIDER: S-EPMC12936832 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature